Apr 29, 2003

Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study

The Journal of Clinical Psychiatry
Antonio CiapparelliGiovanni B Cassano

Abstract

The aim of this study was to evaluate the long-term efficacy and safety of clozapine in patients with treatment-resistant schizophrenia, schizoaffective disorder, or bipolar disorder with psychotic features. 101 patients with a DSM-III-R diagnosis of schizophrenia (N = 34); schizoaffective disorder, bipolar type (N = 30); or bipolar disorder with psychotic features (N = 37) were naturalistically treated with clozapine at flexible doses over a 48-month period. Data were collected from 1994 to 2000. The Brief Psychiatric Rating Scale (BPRS) and Clinical Global Impressions-Severity of Illness scale total predicted scores over time were estimated with random-effects regression models. Time to response to clozapine, defined as 50% reduction of BPRS score, was analyzed in the 3 diagnostic groups using the Kaplan-Meier method. Survival curves were compared using the log-rank test. The BPRS total predicted score halved its baseline value in 3 months for bipolar disorder patients, in 6 months for schizoaffective disorder patients, and in 24 months for schizophrenia patients. The proportion of subjects who satisfied the criterion for response to clozapine after 48 months of follow-up was significantly (p <.01) higher in the schizoaffecti...Continue Reading

  • References
  • Citations52

References

  • We're still populating references for this paper, please check back later.

Mentioned in this Paper

Antipsychotic Effect
Schizophrenia
Clozapine
Severity of Illness Index
Survival Analysis
Global Assessment of Functioning
Bipolar Disorder
Manic Disorder
Dropouts
Brief Psychiatric Rating Scale

About this Paper

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists
M L SilversteinL Fogg
The British Journal of Psychiatry : the Journal of Mental Science
M Maj
© 2020 Meta ULC. All rights reserved